The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate.

The anti-gp41 virus neutralizing monoclonal antibody 2F5 was infused into chimpanzees, which were then given an intravenous challenge with a primary human immunodeficiency virus type I (HIV-1) isolate. In two control animals, the infection was established immediately, as evidenced by positive cell-a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Conley, A J, Kessler JA, I I, Boots, L J, McKenna, P M, Schleif, W A, Emini, E A, Mark, G E, Katinger, H, Cobb, E K, Lunceford, S M, Rouse, S R, Murthy, K K
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1996
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC190718/
https://ncbi.nlm.nih.gov/pubmed/8794312
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak